1. Home
  2. DCTH vs NEON Comparison

DCTH vs NEON Comparison

Compare DCTH & NEON Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • DCTH
  • NEON
  • Stock Information
  • Founded
  • DCTH 1988
  • NEON 1997
  • Country
  • DCTH United States
  • NEON Sweden
  • Employees
  • DCTH 76
  • NEON N/A
  • Industry
  • DCTH Medical/Dental Instruments
  • NEON Industrial Machinery/Components
  • Sector
  • DCTH Health Care
  • NEON Technology
  • Exchange
  • DCTH Nasdaq
  • NEON Nasdaq
  • Market Cap
  • DCTH 426.3M
  • NEON 428.0M
  • IPO Year
  • DCTH N/A
  • NEON 2007
  • Fundamental
  • Price
  • DCTH $11.52
  • NEON $25.46
  • Analyst Decision
  • DCTH Strong Buy
  • NEON Strong Buy
  • Analyst Count
  • DCTH 4
  • NEON 1
  • Target Price
  • DCTH $24.00
  • NEON $16.50
  • AVG Volume (30 Days)
  • DCTH 850.4K
  • NEON 753.1K
  • Earning Date
  • DCTH 08-04-2025
  • NEON 08-07-2025
  • Dividend Yield
  • DCTH N/A
  • NEON N/A
  • EPS Growth
  • DCTH N/A
  • NEON N/A
  • EPS
  • DCTH N/A
  • NEON N/A
  • Revenue
  • DCTH $53,850,000.00
  • NEON $2,807,000.00
  • Revenue This Year
  • DCTH $155.42
  • NEON N/A
  • Revenue Next Year
  • DCTH $37.93
  • NEON $39.01
  • P/E Ratio
  • DCTH N/A
  • NEON N/A
  • Revenue Growth
  • DCTH 1068.87
  • NEON N/A
  • 52 Week Low
  • DCTH $7.17
  • NEON $2.22
  • 52 Week High
  • DCTH $18.23
  • NEON $28.08
  • Technical
  • Relative Strength Index (RSI)
  • DCTH 32.83
  • NEON 67.95
  • Support Level
  • DCTH $12.11
  • NEON $24.31
  • Resistance Level
  • DCTH $14.15
  • NEON $28.08
  • Average True Range (ATR)
  • DCTH 0.57
  • NEON 2.05
  • MACD
  • DCTH -0.16
  • NEON -0.02
  • Stochastic Oscillator
  • DCTH 9.67
  • NEON 69.82

About DCTH Delcath Systems Inc.

Delcath Systems Inc is an oncology company. It is focused on the treatment of primary and metastatic liver cancers. The firm's product, Melphalan Hydrochloride for Injection along with the Delcath Hepatic Delivery System, or Melphalan/HDS, is a drug and device combination product, designed to administer high-dose chemotherapy to the liver while controlling systemic exposure and associated side effects. The company operates in one reportable segment which includes the research, development, manufacture, and distribution of hepatic delivery systems for use in the treatment of specific conditions. The Company operates its business in the United States and Europe.

About NEON Neonode Inc.

Neonode Inc provides optical sensing solutions for contactless touch, and gesture sensing and also provides software solutions for machine perception that feature machine learning algorithms to detect and track persons and objects in video streams from cameras and other types of imagers. It markets and sells its solutions to customers in many different markets and segments including, but not limited to, office equipment, automotive, industrial automation, medical, military, and avionics. The company geographically operates in the United States, Japan, South Korea, Germany, Sweden, China, and other regions. A majority of its revenue is generated from Japan.

Share on Social Networks: